NCT04158479 China Extracorporeal Life Support Registry
| NCT ID | NCT04158479 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beijing Anzhen Hospital |
| Condition | Cardiogenic Shock |
| Study Type | OBSERVATIONAL |
| Enrollment | 20,000 participants |
| Start Date | 2017-01-01 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20,000 participants in total. It began in 2017-01-01 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Extracorporeal life support (ECLS), also known as extracorporeal membrane oxygenation (ECMO), is an extracorporeal technique of providing effective cardiac and respiratory support to patients with lungs and/or heart failure. There was a growth in ECLS cases, centers, and center scale in China during the past decade. This multi-center registry was conducted by Chinese Society of Extracorporeal Life Support. The objectives were to investigate China statistics of ECLS and to evaluate the short-term and long-term outcomes of patients with ECLS.
Eligibility Criteria
Inclusion Criteria: * Patients receiving ECMO for circulatory and/or respiratory support Exclusion Criteria: * Refusal of consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04158479 clinical trial?
This trial is open to participants of all sexes, studying Cardiogenic Shock. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04158479 currently recruiting?
Yes, NCT04158479 is actively recruiting participants. Contact the research team at xt.hou@ccmu.edu.cn for enrollment information.
Where is the NCT04158479 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT04158479 clinical trial?
NCT04158479 is sponsored by Beijing Anzhen Hospital. The trial plans to enroll 20,000 participants.